JENNIFER MORRELL: Open Payments
NPI 1649220419 · PEMBROKE PINES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$256 in 14 payments from 10 companies in 2025. Trend: 2023 $1,151 · 2024 $562 · 2025 $256
Food & beverage: $256
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $84 |
| Alnylam Pharmaceuticals Inc. | 1 | $30 |
| Lilly USA, LLC | 1 | $23 |
| SANOFI-AVENTIS U.S. LLC | 1 | $21 |
| Boston Scientific Corporation | 1 | $20 |
| Amgen Inc. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Exact Sciences Corporation | 1 | $17 |
| Acella Pharmaceuticals, LLC | 1 | $15 |
| Novo Nordisk Inc | 1 | $14 |
Products named: UBRELVY, VRAYLAR, GIVLAARI, KISUNLA, TZIELD, QULIPTA, General - Pain Management, OTEZLA.
Industry payments across FL — which companies pay providers there.
